Molecular mechanisms of vascular permeability in diabetic retinopathy.
about
Dexamethasone intravitreal implant in the treatment of diabetic macular edemaThe unfolded protein response and diabetic retinopathyVascular permeability--the essentials5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy.Infrared micropulsed laser treatment for diabetic macular edema--subthreshold versus threshold lesions.Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema.Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.Loss of synaptic connectivity, particularly in second order neurons is a key feature of diabetic retinal neuropathy in the Ins2Akita mouse.Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy.Increased synthesis of leukotrienes in the mouse model of diabetic retinopathy.Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions.PEDF regulates vascular permeability by a γ-secretase-mediated pathway.High glucose disrupts mitochondrial morphology in retinal endothelial cells: implications for diabetic retinopathyComparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop.The expanding role of vascular endothelial growth factor inhibitors in ophthalmology.Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAK.12/15-Lipoxygenase-derived lipid metabolites induce retinal endothelial cell barrier dysfunction: contribution of NADPH oxidaseDiabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF.Hypopyon uveitis following panretinal photocoagulation in a diabetic patient.Targeting Neovascularization in Ischemic Retinopathy: Recent AdvancesCorrelation between diabetic lower-extremity arterial disease and diabetic neuropathy in patients with type II diabetes: an exploratory study.Interocular symmetry of abnormal multifocal electroretinograms in adolescents with diabetes and no retinopathyImbalances in Mobilization and Activation of Pro-Inflammatory and Vascular Reparative Bone Marrow-Derived Cells in Diabetic Retinopathy.Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life studyActivating transcription factor 4 mediates hyperglycaemia-induced endothelial inflammation and retinal vascular leakage through activation of STAT3 in a mouse model of type 1 diabetes.Caspase-14: a novel caspase in the retina with a potential role in diabetic retinopathy.Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy.Examining the role of lipid mediators in diabetic retinopathy.Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vectorVascular endothelial growth factor in eye disease.Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy.Cellular signaling and potential new treatment targets in diabetic retinopathy.Truncated netrin-1 contributes to pathological vascular permeability in diabetic retinopathyActivated VEGF receptor shed into the vitreous in eyes with wet AMD: a new class of biomarkers in the vitreous with potential for predicting the treatment timing and monitoring response.An experimental platform for systemic drug delivery to the retina.Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models.Insights from Genetic Model Systems of Retinal Degeneration: Role of Epsins in Retinal Angiogenesis and VEGFR2 Signaling.Inflammation in diabetic retinopathy.The role of inflammation in the pathogenesis of macular edema secondary to retinal vascular diseases.Genetic difference in susceptibility to the blood-retina barrier breakdown in diabetes and oxygen-induced retinopathy.
P2860
Q26799423-DA64119A-C28E-480C-8150-8500EA0E6A1CQ27000603-52A3D049-5CB0-41BF-8309-5E04E05DEBB1Q28085112-F08FC707-5BB3-44F1-9637-2D2AE7D0239DQ30393975-C7F4D22A-59DE-4F7C-B393-AFE8B5260194Q31121097-84591F63-87B2-4FAF-9629-251B4A0BFB14Q31136758-B6757F5F-52E9-496C-AE01-8481C67F4AAAQ33641986-D2B7860F-2767-4A7E-9B14-DCDA154D37CBQ33645320-33D7D478-3CBC-4ABF-A951-6DDAAD9C0AC1Q33703836-75A03211-1AE5-428C-B008-CCC6777020D8Q33845208-689EFF60-1BF5-4386-92E2-0C66209A1BA2Q33906155-D94943C9-226B-4725-8725-E4257F1CB6A7Q33939170-7CDC9DA1-F363-435D-B5DE-FBA60799308DQ33947328-D3153FA7-FA5F-4CE8-9D24-C04BF86FA410Q34081378-12E939D4-E6CE-4CC1-9AF6-293A41ED6E58Q34115840-4312126A-8047-4993-8BFB-D4810728BA12Q34525997-A71E7583-5AF6-4AB8-B349-F703C3A4410DQ34600290-1E0359BA-8F72-49CA-9A35-71C9BDD65665Q34733351-75445301-CD1A-4D5E-90A5-4DFF0766F170Q34942714-4B5507B5-92E4-4E22-AAAD-3109D0BF6E18Q34972210-32436125-D5E7-4D9A-97C1-461E6C52D11AQ35173922-5A753F21-8035-45B4-8430-E70EC99C85BEQ35797240-EC04D67F-6F25-4EE2-B02C-0990695AB8BDQ35892696-38224FD7-072D-49AE-94FD-10CFCAAA91A3Q36088924-D4D9084F-D0B4-4117-8617-8DFABC257809Q36144061-029F2B9A-231B-45D2-A82F-7442FAF55511Q36145936-4B22B2A3-83CF-45C7-A43A-8063372B828BQ36311041-ACCE670F-E577-4FEE-B054-20F958383C90Q36808421-AC793261-FB15-4EC0-87E4-00708ACD7355Q36869329-ECF8B055-519B-48AA-A1A4-DA039BA8B873Q36929380-3C6CEF9D-F938-4203-9EC2-289F7AFE25A5Q37084522-0EF3F589-CF53-4DCA-B16C-9CE414E59231Q37089750-15F7D487-8141-4490-A9DE-39342A567BEEQ37137887-2A0B0E9B-2F73-4FFB-9B9E-D0D62FE90E10Q37184559-70E2190B-A4D0-4496-802B-6E140990BCCDQ37384028-D62B13FD-7062-446E-891D-B7EFE8E0FED7Q37462697-0ECEF17E-6F87-4166-971A-5522DDD37B15Q37636830-8888E8EB-B0E4-4A01-836F-0813DB7E0408Q37884176-8674ED6E-1EFC-40CF-BDE9-75290D1CF49CQ38242801-6114AE8D-DD3F-42AF-8EE7-A93DC3125FE1Q38585087-C984F388-9E3F-4CDB-BC85-6FDCABC60A39
P2860
Molecular mechanisms of vascular permeability in diabetic retinopathy.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Molecular mechanisms of vascular permeability in diabetic retinopathy.
@ast
Molecular mechanisms of vascular permeability in diabetic retinopathy.
@en
type
label
Molecular mechanisms of vascular permeability in diabetic retinopathy.
@ast
Molecular mechanisms of vascular permeability in diabetic retinopathy.
@en
prefLabel
Molecular mechanisms of vascular permeability in diabetic retinopathy.
@ast
Molecular mechanisms of vascular permeability in diabetic retinopathy.
@en
P2093
P2860
P1476
Molecular mechanisms of vascular permeability in diabetic retinopathy.
@en
P2093
P2860
P304
P356
10.3109/08820539909069543
P407
P577
1999-12-01T00:00:00Z